Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD
OVID-AMD
1 other identifier
interventional
50
1 country
1
Brief Summary
Objectives: The investigators conducted a prospective study in Belgium with the objective to determine the proportion of subjects identified at moderate-to-high risk for AMD, based on the STARS® questionnaire, in need of nutritional supplementation by assessing their vitamin D, zinc oxide and fatty acid profile status. Methods: This multicentre epidemiological intervention pilot study involved 50 Belgian subjects with no AMD or early AMD, aged over 55, at moderate-to-high risk for AMD based on a simplified AMD risk assessment scale (STARS®) score ≥ 10, not taking vitamin D or trace nutrient containing supplements. Outcome data was collected during a one-time subject interview comprising of clinical eye examinations (typically visual acuity), the STARS® questionnaire, visual acuity assessment, an OCT scan on the macula, and fundus photography. Blood samples were collected from the patients and serum analysis was performed to determine the levels of omega-6 to omega-3 ratio, EPA and DHA, zinc and cupric oxide, and vitamin D, recognised as key nutrients involved in AMD pathophysiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2017
CompletedFirst Submitted
Initial submission to the registry
July 7, 2020
CompletedFirst Posted
Study publicly available on registry
July 22, 2020
CompletedJune 27, 2024
July 1, 2020
6 months
July 7, 2020
June 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
concentration of vitamin D
vitamin D deficiency
at the time of the procedure
Secondary Outcomes (2)
concentration of fatty acids
at the time of the procedure
concentration of zinc oxide
at the time of the procedure
Study Arms (1)
pilot study 1 arm
OTHER50 subjects with no AMD or early AMD, aged over 55, at moderate-to-high risk for AMD based on a simplified AMD risk assessment scale score \> or = 10, not taking vitamin D or trace nutriënt containing supplements
Interventions
blood sample to determine omega6/omega 3 ratio, EPA, DHA, zinc, cupric oxide, vitamine D
Eligibility Criteria
You may qualify if:
- age over 55
- STARS score \> or = 10 (moderate to high risk for AMD)
You may not qualify if:
- STARS score \< 10
- persons taking nutritional supplements containing vitamin D or trace nutrients in the 4 months prior to enrollment
- persons with grade-3 or grade-4 AMD scores according to the AREDS simplified scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- Laboratoires Theacollaborator
Study Sites (1)
UZLeuven
Leuven, 3000, Belgium
Related Publications (1)
Jacob J, Mangelschots E, Michez M, Sanak SN, Leys A. Cross-Sectional Study on Vitamin D, Zinc Oxide and Fatty Acid Status in a Population with a Moderate to High Risk of AMD Identified by the STARS(R) Questionnaire. Ophthalmol Ther. 2021 Jun;10(2):299-311. doi: 10.1007/s40123-021-00335-4. Epub 2021 Feb 23.
PMID: 33620690DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Jacob, MD PhD
Universitaire Ziekenhuizen KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- blood results were communicated to each participant
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2020
First Posted
July 22, 2020
Study Start
April 20, 2017
Primary Completion
October 5, 2017
Study Completion
October 5, 2017
Last Updated
June 27, 2024
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share
results will be published